Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 11 2021
Historique:
received: 04 10 2020
accepted: 27 05 2021
pubmed: 10 7 2021
medline: 1 4 2022
entrez: 9 7 2021
Statut: ppublish

Résumé

Pulsed field ablation (PFA), a non-thermal ablative modality, may show different effects on the myocardial tissue compared to thermal ablation. Thus, this study aimed to compare the left atrial (LA) structural and mechanical characteristics after PFA vs. thermal ablation. Cardiac magnetic resonance was performed pre-ablation, acutely (<3 h), and 3 months post-ablation in 41 patients with paroxysmal atrial fibrillation (AF) undergoing pulmonary vein (PV) isolation with PFA (n = 18) or thermal ablation (n = 23, 16 radiofrequency ablations, 7 cryoablations). Late gadolinium enhancement (LGE), T2-weighted, and cine images were analysed. In the acute stage, LGE volume was 60% larger after PFA vs. thermal ablation (P < 0.001), and oedema on T2 imaging was 20% smaller (P = 0.002). Tissue changes were more homogeneous after PFA than after thermal ablation, with no sign of microvascular damage or intramural haemorrhage. In the chronic stage, the majority of acute LGE had disappeared after PFA, whereas most LGE persisted after thermal ablation. The maximum strain on PV antra, the LA expansion index, and LA active emptying fraction declined acutely after both PFA and thermal ablation but recovered at the chronic stage only with PFA. Pulsed field ablation induces large acute LGE without microvascular damage or intramural haemorrhage. Most LGE lesions disappear in the chronic stage, suggesting a specific reparative process involving less chronic fibrosis. This process may contribute to a preserved tissue compliance and LA reservoir and booster pump functions.

Identifiants

pubmed: 34240134
pii: 6317562
doi: 10.1093/europace/euab155
pmc: PMC8576285
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1767-1776

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007781
pubmed: 31826647
J Cardiovasc Electrophysiol. 2014 Jul;25(7):671-9
pubmed: 24798070
Pacing Clin Electrophysiol. 2006 Mar;29(3):278-82
pubmed: 16606395
J Am Coll Cardiol. 2013 Feb 5;61(5):582-8
pubmed: 23273396
Am J Pathol. 2007 Jun;170(6):1807-16
pubmed: 17525249
J Am Coll Cardiol. 2011 Jul 5;58(2):177-85
pubmed: 21718914
Circulation. 2003 Apr 22;107(15):2004-10
pubmed: 12681994
J Am Coll Cardiol. 2019 Jul 23;74(3):315-326
pubmed: 31085321
Circulation. 2009 Apr 7;119(13):1758-67
pubmed: 19307477
JACC Cardiovasc Imaging. 2017 Feb;10(2):207-208
pubmed: 27085430
Front Physiol. 2020 Apr 08;11:301
pubmed: 32322219
J Cell Sci. 2007 May 15;120(Pt 10):1801-9
pubmed: 17456553
J Cardiovasc Electrophysiol. 2015 May;26(5):484-92
pubmed: 25727248
Pacing Clin Electrophysiol. 2012 Apr;35(4):449-55
pubmed: 22242681
Ann Biomed Eng. 2005 Feb;33(2):223-31
pubmed: 15771276
Front Immunol. 2017 Aug 02;8:909
pubmed: 28824635
J Mol Cell Cardiol. 2014 May;70:74-82
pubmed: 24321195
J Cardiovasc Magn Reson. 2013 Dec 20;15:105
pubmed: 24359544
Eur Radiol. 2017 Apr;27(4):1404-1415
pubmed: 27491873
Europace. 2020 Mar 1;22(3):434-439
pubmed: 31876913
Heart Rhythm. 2011 Sep;8(9):1364-71
pubmed: 21354332

Auteurs

Yosuke Nakatani (Y)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Soumaya Sridi-Cheniti (S)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Pessac, France.

Ghassen Cheniti (G)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

F Daniel Ramirez (FD)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Cyril Goujeau (C)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Clementine André (C)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Takashi Nakashima (T)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Charles Eggert (C)

Farapulse, Menlo Park, CA, USA.

Christopher Schneider (C)

Farapulse, Menlo Park, CA, USA.

Raju Viswanathan (R)

Farapulse, Menlo Park, CA, USA.

Philipp Krisai (P)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Takamitsu Takagi (T)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Tsukasa Kamakura (T)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Konstantinos Vlachos (K)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Nicolas Derval (N)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Josselin Duchateau (J)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Thomas Pambrun (T)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Remi Chauvel (R)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Vivek Y Reddy (VY)

Department of Cardiac Arrhythmia, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Michel Montaudon (M)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

François Laurent (F)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Frederic Sacher (F)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Mélèze Hocini (M)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Michel Haïssaguerre (M)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Pierre Jaïs (P)

Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Hubert Cochet (H)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Pessac, France.
IHU LIRYC-CHU Bordeaux/Univ. Bordeaux/Inserm U1045, Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH